Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 29, 800-806, April 1, 1969]
© 1969 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Froese, G.
Right arrow Articles by Linford, J. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Froese, G.
Right arrow Articles by Linford, J. H.

A Comparison of the Biologic Activities and of the Chemical Properties of Chlorambucil and Trenimon1

G. Froese, J. F. Hamade and J. H. Linford

Manitoba Cancer Foundation, and the Department of Anatomy and Internal Medicine, University of Manitoba, Winnipeg 3, Manitoba, Canada

Chlorambucil and Trenimon are alkylating agents which are in current clinical use for the treatment of malignant diseases. A comparison of their biologic action on V79-1 Chinese hamster cells growing in vitro, was made by measurement of division delay and of the loss of colony-forming ability. With respect to division delay, the qualitative response of the two compounds is similar, but the ratio of the doses for the same quantitative effect is 4000 of Chlorambucil to 1 of Trenimon. With respect to loss of colony-forming ability, a similar large difference was observed in the sensitivity of the cells to the two compounds. A study was made of the effect of pH on the fat solubility of the compounds and on their chemical reactivity. The ability of these two compounds to combine with protein and to interact with red blood cells also has been investigated. The results suggest that the large quantitative difference between the biologic actions of the two compounds is a reflection of the relative abilities of the two compounds to penetrate the cell under the conditions of cell culture which prevailed.

1 These studies have been supported by the National Cancer Institute of Canada.

Received 6/27/68. Accepted 11/30/68.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1969 by the American Association for Cancer Research.